SCHEMBL5237494

SCHEMBL5237494

Cc1cccc(/C(Cc2ccnc3ccccc23)=N\N)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.43
CYP1A2 P05177 1/20 0.43
TGFBR1 P36897 7/20 0.38
MAPK14 Q16539 5/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
HIF1A Q16665 1/20 0.38
P2RX7 Q99572 1/20 0.38
NCF1 P14598 1/20 0.36
FERMT2 Q96AC1 1/20 0.35
HTT P42858 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GALR3 O60755 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
DNMT1 P26358 1/20 0.34
EHMT1 Q9H9B1 1/20 0.34
DNMT3L Q9UJW3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5237411 1.00 LOXL2 (0.43) LOXL2CYP1A2TGFBR1MAPK14CYP3A4
SCHEMBL5236327 0.85 LOXL2 (0.43) LOXL2CYP1A2TGFBR1CYP3A4CYP2D6
SCHEMBL5236321 0.85 LOXL2 (0.43) LOXL2CYP1A2TGFBR1CYP3A4CYP2D6
SCHEMBL5241086 0.85 LOXL2 (0.43) LOXL2CYP1A2TGFBR1MAPK14CYP3A4
SCHEMBL5234647 0.85 LOXL2 (0.45) LOXL2CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL5234654 0.85 LOXL2 (0.45) LOXL2CYP1A2CYP3A4CYP2D6HIF1A
Hydrazine SCHEMBL5232960 0.84 CYP1A2 (0.42) LOXL2CYP1A2TGFBR1MAPK14CYP3A4
SCHEMBL5237043 0.83 LOXL2 (0.49) LOXL2CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL5234977 0.83 LOXL2 (0.49) LOXL2CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL29959459 0.81 CYP1A2 (0.49) LOXL2CYP1A2TGFBR1MAPK14CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397364-B1 NOVEL PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS LILLY CO ELI (US) 2007-07-25 EP disclosed